The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Patients undergo collection of cheek swab, saliva, and hair samples, wear a wrist sleep tracking device, and complete surveys throughout the study."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at sleep changes during breast cancer treatment and possible reasons for poor sleep. It also looks at how stress, support from others, and where people live affect sleep. It is for adults with stage I to III breast cancer that uses hormones to grow, after their main surgery but before chemotherapy or radiation starts.
This study is being done to learn more about breast cancer patients' experiences with sleep changes during cancer treatment, identify possible reasons for poor sleep quality, and to find out how stress, social support, and living environment affect sleep.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Were at least 18 years old when breast cancer was diagnosed.
- Have stage I to III breast cancer that is hormone receptor positive, meaning it uses hormones to grow.
- Have had the main breast cancer surgery but have not started chemotherapy or radiation.
- Have no known return of breast cancer and no second, separate cancer.
- Have had no other new cancer since the breast cancer diagnosis, except non-melanoma skin cancer.
- Can speak, understand, and read English.
- Can understand and complete the study tasks.
- Can access medical records from the hospital where they were treated.
Who can't join
- Have stage IV or metastatic breast cancer, meaning it has spread to distant parts of the body.
- Cannot understand the study well enough to give informed consent, meaning agreement to take part.
- Are not willing to give informed consent to take part.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * \* Age \>= 18 years old at time of breast cancer diagnosis * Stage I to III breast cancer diagnosis * Hormone receptor positive breast cancers * Post primary surgery, before chemotherapy/radiation therapy begins * No known evidence of breast cancer recurrence (local or distant) or second, primary cancer * No prior history of new other malignancy since their breast cancer diagnosis (other than non-melanoma skin cancer) * Able to speak, understand and read English * Cognitively able to complete the study requirements * Ability to access medical records from treating hospital Exclusion Criteria: * \* Stage IV or metastatic breast cancer * Not cognitively able to provide informed consent * Not willing to provide informed consent
Study sites (1)
OH
- Ohio State University Comprehensive Cancer Center · Columbus, OH 43210Electra D. Paskett, MSPH, PhD, FAACR · Study contact · 614-293-3917 · Electra.Paskett@osumc.eduElectra D. Paskett, MSPH, PhD, FAACR · Principal investigatorMore trials in Columbus